Search Videos and More

Showing 1 - 4 of 4 results

Tracing a Career of Unrelenting Discovery News

Tracing a Career of Unrelenting Discovery

Dr. Ben Ebert's Legacy of Collaborative Research Fuels Innovation at Dana-Farber
Kimberly Stegmaier named as Pediatric Oncology Chair at Dana-Farber News

Kimberly Stegmaier named as Pediatric Oncology Chair at Dana-Farber

Kimberly Stegmaier, MD, was named Chair of Pediatric Oncology at Dana-Farber Cancer Institute and Associate Chief of the Division of Hematology/Oncology at Boston Children’s Hospital, in an announcement made today. Her appointment is effective April 1, 2025.
Dana-Farber President and CEO Laurie Glimcher, MD, Announces Her Plans to Step Down Capping a Highly Successful Tenure Marked with Discovery and Innovation News

Dana-Farber President and CEO Laurie Glimcher, MD, Announces Her Plans to Step Down Capping a Highly Successful Tenure Marked with Discovery and Innovation

Acclaimed medical oncologist and researcher Benjamin Ebert, MD, PhD, appointed to lead the world-renowned cancer center
William Hahn is a 2023 Award of Excellence Honoree by Hope Funds News

William Hahn is a 2023 Award of Excellence Honoree by Hope Funds

William Hahn, MD, PhD, executive vice president and chief operating officer at Dana-Farber Cancer Institute, is one of three exceptional individuals honored by Hope Funds with its 2023 Award of Excellence in the areas of Basic Science and Medicine.